Buy & Sell Bank of Montreal (BMO) – Bank of Montreal Price Today
Aura AI Summary
Key Stats
- $109.55BMarket Cap
- FinancialsSector
- -11.62%3M Drawdown
- -Enterprise Value
- 3.15%Dividend Yield
- 0% Buy | 100% SellTrading Activity
- 80 daysTypical Hold Time
Bank of Montreal (BMO) is currently valued at a market capitalization of $109.55B. Over the past 52 weeks, Bank of Montreal has traded between a low of $98.04 and a high of $155.02, highlighting its annual price range. Over the past three months, Bank of Montreal has recorded a drawdown of -11.62%, reflecting recent price volatility. Bank of Montreal offers a dividend yield of 3.15%, with the most recent dividend of $1.67 paid on 29 Apr 26. On average, investors hold Bank of Montreal for approximately 80 days, indicating typical investor behavior on the platform.
About Bank of Montreal
Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
Most Recent News
Incannex Healthcare wins award for innovative drug IHL-42X treating obstructive sleep apnea.
Incannex Healthcare has been recognized by MedTech Breakthrough with the "Best New Technology Solution for Drug Development" award for its lead drug candidate IHL-42X, an oral combination therapy for obstructive sleep apnea (OSA). IHL-42X combines dr...
Fredonia expands El Dorado–Monserrat gold-silver district by 50%, acquiring 11,754 hectares from Pan American Silver.
Fredonia Mining Inc. has acquired approximately 11,754 hectares of mineral properties from a Pan American Silver subsidiary, expanding its El Dorado–Monserrat (EDM) gold-silver project in Argentina to about 33,500 hectares—a 50% increase. This acquis...
Medical marijuana market set to exceed $130B by 2030, driven by legalization and rising demand.
The global medical marijuana market is rapidly growing, expected to reach over $130 billion by the early to mid-2030s due to expanding legalization, increased clinical adoption, and rising demand for non-opioid treatments. Companies like Herbal Dispa...